Medtronic (MDT) Upgraded As It Is Too Cheap Relative To Peers

December 22, 2010 11:51 AM EST Send to a Friend
As noted earlier, UBS upgraded Medtronic, Inc. (NYSE: MDT) from Neutral to Buy today and raised their price target form ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login